Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Execs On The Move, October 2014

Executive Summary

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

You may also be interested in...



Remibrutinib REMIXes The Itch Record

Pivotal data on the oral BTK inhibitor could enable Novartis to maintain its hold on the urticaria market.

EU Parliament OKs Legislation To ‘Reduce Cost & Burden’ Of Patent Extensions

Legislation intended to remove the fragmentation in the supplementary protection certificate system has been OKd by the European Parliament, which will try to reach agreement with the EU member states following the June parliamentary elections.

How Lilly Is Helping To Address The UK’s ‘Postcode Lottery’ For Cancer Drugs

Some innovative cancer drugs are not reaching eligible patients in the UK, despite securing positive reimbursement opinions from NICE. Eli Lilly explains how industry can be “part of the solution” through partnership initiatives.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel